Combined lamivudine and hepatitis B immunoglobulin for the prevention of hepatitis B recurrence after liver transplantation: long-term results.
about
Lamivudine or adefovir dipivoxil alone or combined with immunoglobulin for preventing hepatitis B recurrence after liver transplantationImpact of virologic breakthrough and HBIG regimen on hepatitis B recurrence after liver transplantationOne year of hepatitis B immunoglobulin plus tenofovir therapy is safe and effective in preventing recurrent hepatitis B post-liver transplantationContradictory immune response in post liver transplantation hepatitis B and C.YMDD variants of HBV DNA polymerase gene: rapid detection and clinicopathological analysis with long-term lamivudine therapy after liver transplantation.Comparison of real-time PCR assays for monitoring serum hepatitis B virus DNA levels during antiviral therapy.Prevention of hepatitis C virus infection using a broad cross-neutralizing monoclonal antibody (AR4A) and epigallocatechin gallateHepatitis B immunoglobulin and Lamivudine improve hepatitis B-related outcomes after liver transplantation: meta-analysisHepatitis B immunoglobulin in preventing reinfection following liver transplantation.Hepatitis B immunoglobulins and/or lamivudine for preventing hepatitis B recurrence after liver transplantation: a systematic review.The role of HBIg as hepatitis B reinfection prophylaxis following liver transplantation.Hepatitis B immunoglobulin and/or nucleos(t)ide analogues for prophylaxis against hepatitis b virus recurrence after liver transplantation: a systematic review.Management of viral infections in solid organ transplant recipients.Hepatitis B immune globulin in liver transplantation prophylaxis: an update.High genetic barrier nucleos(t)ide analogue(s) for prophylaxis from hepatitis B virus recurrence after liver transplantation: a systematic review.Safe and cost-effective control of post-transplantation recurrence of hepatitis B.Effect of prior hepatitis B virus exposure on long-term risk of liver-related events after liver transplantation.Frequent incidence of escape mutants after successful hepatitis B vaccine response and stopping of nucleos(t)ide analogues in liver transplant recipients.Viral hepatitis in solid organ transplantation.Different effect of HBV vaccine after liver transplantation between chronic HBV carriers and non-HBV patients who received HBcAb-positive grafts.Review article: hepatitis B core-related antigen (HBcrAg): an emerging marker for chronic hepatitis B virus infection.Anti-hepatitis B surface immunoglobulin reduction in early postoperative period after liver transplantation in hepatitis B virus-positive patients.Pharmacology, clinical efficacy and safety of lamivudine in hepatitis B virus infection.Long-term results after liver transplantation.
P2860
Q24234338-1BBDFDD1-9F22-4C98-95AE-B8C7F894536BQ30431207-2CAE034C-642B-4DBF-9D40-E3FF69BDD2E8Q33810155-FE95C68A-A665-4DBB-A61C-D04F3ECEDF96Q34152074-92B4E2A6-5123-4CEE-930B-99200A60E40DQ35011213-E4356B03-4D90-404D-908C-26D508D63B39Q35073177-B64AF222-BBA7-46DE-AD14-E6A020004D89Q36624431-16B8CAE1-D58A-4755-9AF1-476ABE91D0F0Q37310932-6FD8EB8F-FD83-4173-A7FC-21E4267D3FCBQ37432104-A467FFC5-3C2A-48FE-A811-8F7802C8E9B2Q37764964-9E9331A1-9549-4E12-B54A-749F91CF954FQ37870833-38716F32-801D-4A02-A983-22F50B98685FQ37886893-AD938C64-91D0-414E-81FB-711DC8BA0AACQ37892559-6B275169-96B6-4750-B756-4C4A44AA5118Q38006958-BE3D83F4-9C1B-463D-878D-2B80C9404292Q38058545-57EF5F93-3D96-496B-AEAD-85D0E545B074Q38218260-9A486C19-2B20-418A-9615-636616150647Q38749310-CC18443C-41AC-456B-93AA-069CEB23D67DQ42210316-54AF98A4-8E80-4DDF-B7F3-1A4EC404409BQ42272319-CF44781E-3B4A-4BA4-8D43-4A9C7A2A45BFQ43640407-323E0FC3-DC9E-4132-93DF-FB892DD20E6EQ45326295-C1C8F0EB-FDA8-42DC-97EC-2650D4D4ED41Q45362944-A42C0E81-1C3C-482E-9742-AC1D8E3827A9Q45388069-8C3DD269-7080-497F-A3B1-C410EFAD985AQ52922055-3E78D367-F3BA-4A11-BDF9-8275E485E766
P2860
Combined lamivudine and hepatitis B immunoglobulin for the prevention of hepatitis B recurrence after liver transplantation: long-term results.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh-hant
name
Combined lamivudine and hepati ...... plantation: long-term results.
@en
Combined lamivudine and hepati ...... plantation: long-term results.
@nl
type
label
Combined lamivudine and hepati ...... plantation: long-term results.
@en
Combined lamivudine and hepati ...... plantation: long-term results.
@nl
prefLabel
Combined lamivudine and hepati ...... plantation: long-term results.
@en
Combined lamivudine and hepati ...... plantation: long-term results.
@nl
P2093
P2860
P1476
Combined lamivudine and hepati ...... plantation: long-term results.
@en
P2093
Françoise Berger
Jean-Yves Scoazec
Jérôme Dumortier
Olivier Boillot
Philippe Chevallier
P2860
P304
P356
10.1034/J.1600-6143.2003.00191.X
P407
P577
2003-08-01T00:00:00Z